8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 28, 2021

 

SS&C TECHNOLOGIES HOLDINGS, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware	001-34675	71-0987913
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

80 Lamberton Road, Windsor, CT	06095
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (860) 298-4500

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common stock, par value $0.01 per share	SSNC	The Nasdaq Global Select Market

Item 2.02. Results of Operations and Financial Condition

On October 28, 2021, SS&C Technologies Holdings, Inc. (the “Company”) announced its financial results for the quarter ended September 30, 2021. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. On October 28, 2021, the Company also posted a Q3 2021 Earnings Results Presentation dated October 28, 2021, on the Company’s Investor Relations website at investor.ssctech.com.

The information in this Form 8-K (including Exhibit 99.1 and 99.2) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

The following exhibits relating to Item 2.02 shall be deemed to be furnished, and not filed:

99.1	Press Release, issued by the Company on October 28, 2021.
99.2	Q3 2021 Earnings Presentation dated October 28, 2021.
104	The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SS&C TECHNOLOGIES HOLDINGS, INC.
Date: October 28, 2021	By:	/s/ Patrick J. Pedonti
		Patrick J. Pedonti
		Senior Vice President and Chief Financial Officer

EX-99.1

 

Exhibit 99.1

SS&C Technologies Releases Q3 2021 Earnings Results

Q3 2021 GAAP revenue $1,264.4 million, up 9.7%, Fully Diluted GAAP Earnings Per Share $0.69, up 15.0%

Adjusted revenue $1,266.3 million, up 9.5%, Adjusted Diluted Earnings Per Share $1.32, up 20.0%

WINDSOR, CT, October 28, 2021 (PR Newswire) SS&C Technologies Holdings, Inc. (NASDAQ: SSNC), a global provider of investment, financial and healthcare software-enabled services and software, today announced its financial results for the third quarter and nine months ended September 30, 2021.

	Three Months Ended September 30,			Nine Months Ended September 30,
(in millions, except per share data):	2021	2020	Change	2021	2020	Change
GAAP Results
Revenue	$1,264.4	$1,152.8	9.7%	$3,756.8	$3,464.5	8.4%
Operating income	340.1	257.0	32.3%	922.1	717.1	28.6%
Operating income margin	26.9%	22.3%	460 bp	24.5%	20.7%	380 bp
Diluted earnings per share attributable to SS&C	$0.69	$0.60	15.0%	$2.05	$1.61	27.3%
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)
Adjusted revenue	$1,266.3	$1,156.2	9.5%	$3,762.7	$3,475.0	8.3%
Adjusted operating income attributable to SS&C	524.1	448.8	16.8%	1,495.7	1,323.1	13.0%
Adjusted operating income margin	41.4%	38.8%	260 bp	39.8%	38.1%	170 bp
Adjusted diluted earnings per share attributable to SS&C	$1.32	$1.10	20.0%	$3.75	$3.17	18.3%

Third Quarter 2021 Highlights:

Adjusted organic revenue growth for Q3 2021 was 8.2%.

SS&C reported record adjusted consolidated EBITDA attributable to SS&C of $538.9 million for the quarter, $1,541.9 million for the first nine months 2021.

Adjusted consolidated EBITDA margin increased to 42.6%, up 230 bps from Q3 2020.

Repurchased 2.1 million shares of common stock in Q3 2021 at an average price of $75.97 per share for $162.9 million.

Paid down $317.8 million in debt for the first nine months in 2021, bringing consolidated net leverage ratio to 2.96x and our secured net leverage ratio to 1.97x consolidated EBITDA attributable to SS&C.

In September, the vast majority of global offices re-opened and employees are attending in increasing numbers on a voluntary basis.

SS&C will host a virtual analyst day on November 10th, 2021, featuring presentations from our C-suite executives, as well as several members of our senior management team.

 

 

“SS&C continues to gain momentum from the first half of year, and this quarter recorded 9.5 percent adjusted revenue growth, 8.2 percent adjusted organic revenue growth. Our business is running on all cylinders: our sales force is executing, our developers are rolling out new products, and our customer service levels are high,” says Bill Stone, Chairman and Chief Executive Officer. “Our businesses are capitalizing on the strong end markets, particularly in Alternatives and M&A, where our market leading position continues to solidify. We are optimistic to close out 2021 strong.”

Operating Cash Flow

SS&C generated net cash from operating activities of $944.9 million for the nine months ended September 30, 2021, compared to $755.1 million for the same period in 2020, a 25.1% increase. SS&C ended the third quarter with $351.1 million in cash and cash equivalents and $6,190.3 million in gross debt. SS&C’s net debt balance as defined in our credit agreement, which excludes cash and cash equivalents of $138.3 million held at DomaniRx, LLC was $5,977.5 million as of September 30, 2021. SS&C’s consolidated net leverage ratio as defined in our credit agreement stood at 2.96 times consolidated EBITDA attributable to SS&C as of September 30, 2021. SS&C’s net secured leverage ratio stood at 1.97 times consolidated EBITDA attributable to SS&C as of September 30, 2021.

Guidance

	Q4 2021	FY 2021
Adjusted Revenue ($M)	$1,225.0 – $1,275.0	$4,988.0 – $5,038.0
Adjusted Net Income attributable to SS&C ($M)	$311.0 – $334.0	$1,312.0 – $1,335.0
Adjusted Diluted Earnings per Share attributable to SS&C	$1.17 – $1.25	$4.92 – $4.99
Cash from Operating Activities ($M)	–	$1,365.0 – $1,385.0
Capital Expenditures (% of revenue)	–	2.6% – 3.0%
Diluted Shares (M)	266.2 – 266.7	266.9 – 267.4
Effective Income Tax Rate (%)	26%	26%

SS&C does not provide reconciliations of guidance for Adjusted Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. SS&C is unable, without unreasonable efforts, to forecast certain items required to develop meaningful comparable GAAP financial measures. These items include acquisition transactions and integration, foreign exchange rate changes, as well as other non-cash and other adjustments as defined under the Company’s Credit agreement, that are difficult to predict in advance in order to include in a GAAP estimate. The unavailable information could have a significant impact on Q4 2021 and FY 2021 GAAP financial results.

Non-GAAP Financial Measures

Adjusted revenue, adjusted operating income, adjusted consolidated EBITDA, adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See the accompanying notes for the reconciliations and definitions for each of these non-GAAP measures and the reasons our management believes these measures provide useful information to investors regarding our financial condition and results of operations.

 

 

Earnings Call and Press Release

SS&C’s Q3 2021 earnings call will take place at 5:00 p.m. eastern time today, October 28, 2021. The call will discuss Q3 2021 results and business outlook. Interested parties may dial 888-210-4650 (US and Canada) or 646-960-0327 (International), and request the “SS&C Technologies Third Quarter 2021 Earnings Conference Call”; conference ID #4673675. In connection with the earnings call, a presentation will be available on SS&C’s website at http://investor.ssctech.com/results.cfm. A replay will be available after 8:00 p.m. eastern time on October 28, 2021, until midnight on November 4, 2021. The replay dial-in number is 800-770-2030 (US and Canada) or 647-362-9199 (International); access code #4673675. The call will also be available for replay on SS&C’s website after October 28, 2021; access: http://investor.ssctech.com/results.cfm.

Certain information contained in this press release relating to, among other things, the Company’s financial guidance for the fourth quarter and full year of 2021 constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, performance, underlying assumptions, and other statements that are other than statements of historical facts.Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “estimates”, “projects”, “forecasts”, “may”, “assume”, “intend”, “will”, “continue”, “opportunity”, “predict”, “potential”, “future”, “guarantee”, “likely”, “target”, “indicate”, “would”, “could” and “should” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Such statements reflect management’s best judgment based on factors currently known but are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, the state of the economy and the financial services industry and other industries in which the Company’s clients operate, the Company’s ability to realize anticipated benefits from its acquisitions, including DST Systems, Inc., the effect of customer consolidation on demand for the Company’s products and services, the increasing focus of the Company’s business on the hedge fund industry, the variability of revenue as a result of activity in the securities markets, the ability to retain and attract clients, fluctuations in customer demand for the Company’s products and services, the intensity of competition with respect to the Company’s products and services, the exposure to litigation and other claims, terrorist activities and other catastrophic events, disruptions, attacks or failures affecting the Company’s software-enabled services, risks associated with the Company’s foreign operations, privacy concerns relating to the collection and storage of personal information, evolving regulations and increased scrutiny from regulators, the Company’s ability to protect intellectual property assets and litigation regarding intellectual property rights, delays in product development, investment decisions concerning cash balances, regulatory and tax risks, risks associated with the Company’s joint ventures, changes in accounting standards, risks related to the Company’s substantial indebtedness, the market price of the Company’s stock prevailing from time to time, and the risks discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission and can also be accessed on our website. Forward-looking statements speak only as of the date on which they are made and, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements.

 

 

About SS&C Technologies

SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. Some 18,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.

Follow SS&C on Twitter, LinkedIn and Facebook.

For more information

Patrick Pedonti

Chief Financial Officer

Tel: +1-860-298-4738

E-mail: InvestorRelations@sscinc.com

Justine Stone

Investor Relations

Tel: +1-212-367-4705

E-mail: InvestorRelations@sscinc.com

 

SS&C Technologies Holdings, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

(in millions, except per share data)

(unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Revenues:
Software-enabled services	$	1,069.9		$	958.4		$	3,170.4		$	2,892.9
License, maintenance and related		194.5			194.4			586.4			571.6
Total revenues		1,264.4			1,152.8			3,756.8			3,464.5
Cost of revenues:
Software-enabled services		563.7			551.6			1,742.0			1,685.0
License, maintenance and related		76.7			77.3			236.7			236.3
Total cost of revenues		640.4			628.9			1,978.7			1,921.3
Gross profit		624.0			523.9			1,778.1			1,543.2
Operating expenses:
Selling and marketing		96.4			85.2			286.1			260.9
Research and development		97.7			97.0			306.4			298.7
General and administrative		89.8			84.7			263.5			266.5
Total operating expenses		283.9			266.9			856.0			826.1
Operating income		340.1			257.0			922.1			717.1
Interest expense, net		(50.2	)		(54.7	)		(152.6	)		(192.6	)
Other (expense) income, net		(44.9	)		15.1			(20.4	)		18.8
Equity in earnings of unconsolidated affiliates, net		2.0			0.2			1.9			(0.1	)
(Loss) gain on extinguishment of debt		(1.7	)		0.4			(3.5	)		(2.2	)
Income before income taxes		245.3			218.0			747.5			541.0
Provision for income taxes		60.6			58.6			198.1			112.9
Net income		184.7			159.4			549.4			428.1
Net income attributable to noncontrolling interest		(0.3	)		—			(0.3	)		—
Net income attributable to SS&C common stockholders	$	184.4		$	159.4		$	549.1		$	428.1
Basic earnings per share attributable to SS&C common stockholders	$	0.72		$	0.62		$	2.15		$	1.67
Diluted earnings per share attributable to SS&C common stockholders	$	0.69		$	0.60		$	2.05		$	1.61
Basic weighted-average number of common shares outstanding		254.7			256.7			255.8			256.3
Diluted weighted-average number of common and common equivalent shares outstanding		266.5			266.7			267.3			266.0
Net income	$	184.7		$	159.4		$	549.4		$	428.1
Other comprehensive (loss) income, net of tax:
Change in unrealized (loss) gain on interest rate swaps		—			(0.1	)		0.3			(2.8	)
Foreign currency exchange translation adjustment		(55.7	)		70.7			(45.4	)		(45.9	)
Change in defined benefit pension obligation		0.1			—			0.2			—
Total other comprehensive (loss) income, net of tax		(55.6	)		70.6			(44.9	)		(48.7	)
Comprehensive income		129.1			230.0			504.5			379.4
Comprehensive income attributable to noncontrolling interest		(0.3	)		—			(0.3	)		—
Comprehensive income attributable to SS&C common stockholders	$	128.8		$	230.0		$	504.2		$	379.4

SS&C Technologies Holdings, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in millions)

(unaudited)

	September 30,		December 31,
	2021		2020
Assets
Current assets:
Cash and cash equivalents	$	351.1	$	209.3
Funds receivable and funds held on behalf of clients		2,493.1		1,227.4
Accounts receivable, net		715.2		648.0
Contract asset		21.1		20.4
Prepaid expenses and other current assets		192.2		187.5
Restricted cash		3.7		5.9
Total current assets		3,776.4		2,298.5
Property, plant and equipment, net		390.0		412.8
Operating lease right-of-use assets		307.4		350.8
Investments		179.4		183.5
Unconsolidated affiliates		219.7		225.6
Contract asset		81.4		82.0
Goodwill		8,041.9		8,078.7
Intangible and other assets, net		3,937.8		4,291.7
Total assets	$	16,934.0	$	15,923.6
Liabilities and Stockholders’ Equity
Current liabilities:
Current portion of long-term debt	$	91.3	$	53.9
Client funds obligations		2,493.1		1,227.4
Accounts payable		27.5		28.1
Income taxes payable		33.5		9.3
Accrued employee compensation and benefits		260.0		311.5
Interest payable		—		27.5
Other accrued expenses		340.7		293.1
Deferred revenue		325.8		332.5
Total current liabilities		3,571.9		2,283.3
Long-term debt, net of current portion		6,049.4		6,388.5
Operating lease liabilities		283.6		323.6
Other long-term liabilities		273.2		287.9
Deferred income taxes		840.5		923.8
Total liabilities		11,018.6		10,207.1
SS&C stockholders' equity		5,811.1		5,716.5
Noncontrolling interest		104.3		—
Total stockholders’ equity		5,915.4		5,716.5
Total liabilities and stockholders’ equity	$	16,934.0	$	15,923.6

SS&C Technologies Holdings, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in millions)

(unaudited)

	Nine Months Ended September 30,
	2021			2020
Cash flow from operating activities:
Net income	$	549.4		$	428.1
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		500.2			544.1
Equity in earnings of unconsolidated affiliates, net		(1.9	)		0.1
Cash distributions received from unconsolidated affiliates		10.0			8.0
Gain on bargain purchase		(3.2	)		—
Stock-based compensation expense		82.7			65.9
Net gains on investments		(17.3	)		(17.3	)
Amortization and write-offs of loan origination costs and original issue discounts		10.0			10.4
Loss on extinguishment of debt, net		3.5			1.3
Loss on sale or disposition of property and equipment		0.6			4.0
Deferred income taxes		(82.5	)		(115.9	)
Provision for doubtful accounts		6.5			6.0
Changes in operating assets and liabilities, excluding effects from acquisitions:
Accounts receivable		(72.6	)		20.0
Prepaid expenses and other assets		15.8			(86.2	)
Contract assets		(1.1	)		(4.0	)
Accounts payable		(3.3	)		(9.5	)
Accrued expenses and other liabilities		(49.9	)		(80.9	)
Income taxes prepaid and payable		33.8			38.9
Deferred revenue		(35.8	)		(57.9	)
Net cash provided by operating activities		944.9			755.1
Cash flow from investing activities:
Cash paid for business acquisitions, net of cash acquired		7.3			(113.5	)
Additions to property and equipment		(31.0	)		(25.4	)
Proceeds from sale of property and equipment		0.2			—
Additions to capitalized software		(65.2	)		(54.6	)
Investments in securities		(20.1	)		(60.8	)
Proceeds from sales / maturities of investments		42.3			50.8
Collection of other non-current receivables		8.3			7.6
Net cash used in investing activities		(58.2	)		(195.9	)
Cash flow from financing activities:
Cash received from debt borrowings		370.0			286.0
Repayments of debt		(687.8	)		(616.3	)
Net increase (decrease) in client funds obligations		1,226.3			(949.2	)
Proceeds from exercise of stock options		124.2			129.6
Withholding taxes paid related to equity award net share settlement		(5.8	)		(8.1	)
Purchases of common stock for treasury		(487.9	)		(219.8	)
Dividends paid on common stock		(122.8	)		(99.9	)
Proceeds from noncontrolling interests		67.3			—
Net cash provided by (used in) financing activities		483.5			(1,477.7	)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(4.2	)		(2.0	)
Net increase (decrease) in cash, cash equivalents and restricted cash		1,366.0			(920.5	)
Cash, cash equivalents and restricted cash, beginning of period		1,337.9			1,789.4
Cash, cash equivalents and restricted cash and cash equivalents, end of period	$	2,703.9		$	868.9
Reconciliation of cash, cash equivalents and restricted cash and cash equivalents:
Cash and cash equivalents	$	351.1		$	184.5
Restricted cash and cash equivalents		3.7			6.0
Restricted cash and cash equivalents included in funds receivable and funds held on behalf of clients		2,349.1			678.4
	$	2,703.9		$	868.9

SS&C Technologies Holdings, Inc. and Subsidiaries

Disclosures Relating to Non-GAAP Financial Measures

Note 1. Reconciliation of Revenues to Adjusted Revenues

Adjusted revenues represents revenues adjusted to include a) amounts that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition and b) amounts that would have been recognized if not for adjustments to deferred revenue and retained earnings related to the adoption of ASC 606. Adjusted revenues is presented because we use this measure to evaluate performance of our business against prior periods and believe it is a useful indicator of the underlying performance of our business. Adjusted revenues is not a recognized term under generally accepted accounting principles (“GAAP”). Adjusted revenues does not represent revenues, as that term is defined under GAAP, and should not be considered as an alternative to revenues as an indicator of our operating performance. Adjusted revenues as presented herein is not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP measure we believe to be most directly comparable to adjusted revenues.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in millions)	2021		2020		2021		2020
Revenues	$	1,264.4	$	1,152.8	$	3,756.8	$	3,464.5
ASC 606 adoption impact		0.2		1.4		0.4		4.2
Purchase accounting adjustments impact on revenue		1.7		2.0		5.5		6.3
Adjusted revenues	$	1,266.3	$	1,156.2	$	3,762.7	$	3,475.0

The following is a breakdown of software-enabled services and license, maintenance and related revenues and adjusted software-enabled services and license, maintenance and related revenues.

	Three Months Ended September 30,				Nine Months Ended September 30,
(in millions)	2021		2020		2021		2020
Software-enabled services	$	1,069.9	$	958.4	$	3,170.4	$	2,892.9
License, maintenance and related		194.5		194.4		586.4		571.6
Total revenues	$	1,264.4	$	1,152.8	$	3,756.8	$	3,464.5
Software-enabled services	$	1,071.6	$	960.3	$	3,175.8	$	2,898.3
License, maintenance and related		194.7		195.9		586.9		576.7
Total adjusted revenues	$	1,266.3	$	1,156.2	$	3,762.7	$	3,475.0

Note 2. Reconciliation of Operating Income to Adjusted Operating Income

Adjusted operating income represents operating income adjusted for amortization of intangible assets, stock-based compensation, purchase accounting adjustments for deferred revenue and related costs, ASC 606 adoption impact and other expenses. Adjusted operating income is presented because we use this measure to evaluate performance of our business and believe it is a useful indicator of our underlying performance. Adjusted operating income is not a recognized term under GAAP. Adjusted operating income does not represent operating income, as that term is defined under GAAP, and should not be considered as an alternative to operating income as an indicator of our operating performance. Adjusted operating income as presented herein is not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation between adjusted operating income and operating income, the GAAP measure we believe to be most directly comparable to adjusted operating income.

	Three Months Ended September 30,					Nine Months Ended September 30,
(in millions)	2021			2020		2021			2020
Operating income	$	340.1		$	257.0	$	922.1		$	717.1
Amortization of intangible assets		146.8			153.9		437.6			463.9
Stock-based compensation		27.2			21.3		82.7			65.9
Purchase accounting adjustments (1)		4.3			10.2		19.8			30.1
ASC 606 adoption impact		0.3			1.5		0.7			4.4
Other (2)		6.3			4.9		33.7			41.7
Adjusted operating income	$	525.0		$	448.8	$	1,496.6		$	1,323.1
Adjusted operating income attributable to noncontrolling interest (3)		(0.9	)		—		(0.9	)		—
Adjusted operating income attributable to SS&C common stockholders	$	524.1		$	448.8	$	1,495.7		$	1,323.1

(1)Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were

not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition.

(2)Other includes expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance. These include expenses and income related to foreign currency transactions, facilities and workforce restructuring, legal settlements and business acquisitions.

(3)On July 15, 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted operating income attributable to noncontrolling interest represents adjusted operating income based on the ownership interest retained by the respective noncontrolling parties.

Note 3. Reconciliation of Net Income to EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA

EBITDA represents net income before interest expense, income taxes, depreciation and amortization. Consolidated EBITDA, defined under our Credit Agreement entered into in April 2018, as amended, is used in calculating covenant compliance, and is EBITDA adjusted for certain items. Consolidated EBITDA is calculated by subtracting from or adding to EBITDA items of income or expense described below. Adjusted Consolidated EBITDA is calculated by subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we use these measures to evaluate performance of our business and believe them to be useful indicators of an entity’s debt capacity and its ability to service debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not recognized terms under GAAP and should not be considered in isolation or as alternatives to operating income, net income or cash flows from operating activities as indicators of our operating performance. These measures are not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA to net income.

	Three Months Ended September 30,						Nine Months Ended September 30,						Twelve Months Ended September 30,
(in millions)	2021			2020			2021			2020			2021
Net income	$	184.7		$	159.4		$	549.4		$	428.1		$	746.5
Interest expense, net		50.2			54.7			152.6			192.6			206.0
Provision for income taxes		60.6			58.6			198.1			112.9			235.8
Depreciation and amortization		165.0			180.0			500.2			544.1			681.3
EBITDA		460.5			452.7			1,400.3			1,277.7			1,869.6
Stock-based compensation		27.2			21.3			82.7			65.9			104.6
Acquired EBITDA and cost savings (1)		—			—			1.3			2.3			1.8
Non-cash portion of straight-line rent expense		(0.7	)		0.1			(1.4	)		(0.2	)		(1.3	)
Loss (gain) on extinguishment of debt, net		1.7			(0.4	)		3.5			2.2			5.5
Equity in earnings of unconsolidated affiliates, net		(2.0	)		(0.2	)		(1.9	)		0.1			(0.5	)
Purchase accounting adjustments (2)		1.6			1.5			4.8			5.2			6.5
ASC 606 adoption impact		0.3			1.5			0.7			4.4			1.5
Other (3)		51.2			(10.2	)		54.1			22.9			32.7
Consolidated EBITDA	$	539.8		$	466.3		$	1,544.1		$	1,380.5		$	2,020.4
Less: acquired EBITDA and cost savings (1)		—			—			(1.3	)		(2.3	)		(1.8	)
Adjusted Consolidated EBITDA	$	539.8		$	466.3		$	1,542.8		$	1,378.2		$	2,018.6
Adjusted Consolidated EBITDA attributable to noncontrolling interest (4)		(0.9	)		—			(0.9	)		—			(0.9	)
Adjusted Consolidated EBITDA attributable to SS&C common stockholders	$	538.9		$	466.3		$	1,541.9		$	1,378.2		$	2,017.7

(1)Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the period as if the acquisition occurred at the beginning of the period, as well as cost savings enacted in connection with acquisitions.

(2)Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisitions (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to increase or decrease rent expense by the amount that would have been recognized if lease obligations were not adjusted to fair value at the date of acquisitions.

(3)Other includes expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance. These include expenses and income related to foreign currency transactions, investment gains and losses, facilities and workforce restructuring, legal settlements, business combinations and other items.

(4)On July 15, 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted Consolidated EBITDA attributable to noncontrolling interest represents adjusted Consolidated EBITDA based on the ownership interest retained by the respective noncontrolling parties.

Note 4. Reconciliation of Net Income to Adjusted Net Income and Diluted Earnings Per Share Attributable to SS&C to Adjusted Diluted Earnings Per Share Attributable to SS&C

Adjusted net income and adjusted diluted earnings per share attributable to SS&C represent net income and earnings per share attributable to SS&C before amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments and other items. We consider adjusted net income and adjusted diluted earnings per share attributable to SS&C to be important to management and investors because they represent our operational performance exclusive of the effects of amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments, loss on extinguishment of debt and other items, that are not operational in nature or comparable to those of our competitors. Adjusted net income and adjusted diluted earnings per share are not recognized terms under GAAP. Adjusted net income and adjusted diluted earnings per share do not represent net income or diluted earnings per share, as those terms are defined under GAAP, and should not be considered as alternatives to net income or diluted earnings per share as indicators of our operating performance. Adjusted net income and adjusted diluted earnings per share attributable to SS&C as presented herein are not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted net income and adjusted diluted earnings per share attributable to SS&C to net income and diluted earnings per share attributable to SS&C, the GAAP measures we believe to be most directly comparable to adjusted net income and adjusted diluted earnings per share.

	Three Months Ended September 30,						Nine Months Ended September 30,
(in millions, except per share data)	2021			2020			2021			2020
GAAP – Net income	$	184.7		$	159.4		$	549.4		$	428.1
Amortization of intangible assets		146.8			153.9			437.6			463.9
Amortization of deferred financing costs and original issue discount		3.3			3.4			10.0			10.4
Stock-based compensation		27.2			21.3			82.7			65.9
Loss (gain) on extinguishment of debt		1.7			(0.4	)		3.5			2.2
Purchase accounting adjustments (1)		4.3			10.2			19.8			30.1
ASC 606 adoption impact		0.3			1.5			0.7			4.4
Equity in earnings of unconsolidated affiliates, net		(2.0	)		(0.2	)		(1.9	)		0.1
Other (2)		51.2			(10.2	)		54.1			22.9
Income tax effect (3)		(63.7	)		(44.7	)		(153.9	)		(183.8	)
Adjusted net income	$	353.8		$	294.2		$	1,002.0		$	844.2
Adjusted net income attributable to noncontrolling interest (4)		(0.9	)		—			(0.9	)		—
Adjusted net income attributable to SS&C common stockholders	$	352.9		$	294.2		$	1,001.1		$	844.2
Adjusted diluted earnings per share attributable to SS&C common stockholders	$	1.32		$	1.10		$	3.75		$	3.17
GAAP diluted earnings per share attributable to SS&C common stockholders	$	0.69		$	0.60		$	2.05		$	1.61
Diluted weighted-average shares outstanding		266.5			266.7			267.3			266.0

(1)Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition.

(2)Other includes expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance. These include expenses and income related to foreign currency transactions, investment gains and losses, facilities and workforce restructuring, legal settlements, business acquisitions and other items.

(3)An estimated normalized effective tax rate of approximately 26% for the three and nine months ended September 30, 2021 and 2020, respectively, has been used to adjust the provision for income taxes for the purpose of computing adjusted net income.

(4)On July 15, 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted net income attributable to noncontrolling interest represents adjusted net income based on the ownership interest retained by the respective noncontrolling parties.

EX-99.2

SS&C Technologies (NASDAQ:SSNC) Q3 2021 Earnings Results

Safe Harbor Statement This presentation contains forward-looking statements, as defined by federal and state securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, performance or products, underlying assumptions, and other statements which are other than statements of historical facts. In some cases, you can identify forward-looking statements by terminology such as ''may,'' ''will,'' ''should,'' “hope,'' "expects,'' ''intends,'' ''plans,'' ''anticipates,'' "contemplates," ''believes,'' ''estimates,'' ''predicts,'' ''projects,'' ''potential,'' ''continue,'' and other similar terminology or the negative of these terms. From time to time, we may publish or otherwise make available forward-looking statements of this nature. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by the cautionary statements described on this message including those set forth below. All statements contained in this presentation are made only as of the date of this presentation. In addition, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements to reflect events, circumstances, or new information after the date of the information or to reflect the occurrence or likelihood of unanticipated events, and we disclaim any such obligation. Forward-looking statements are only predictions that relate to future events or our future performance and are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause actual results, outcomes, levels of activity, performance, developments, or achievements to be materially different from any future results, outcomes, levels of activity, performance, developments, or achievements expressed, anticipated, or implied by these forward-looking statements. Other factors that could affect actual results, outcomes, levels of activity, performance, developments or achievements can be found under the heading “Risk Factors” in SS&C Technologies Holdings, Inc.’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. As a result, we cannot guarantee future results, outcomes, levels of activity, performance, developments, or achievements, and there can be no assurance that our expectations, intentions, anticipations, beliefs, or projections will result or be achieved or accomplished.

Adjusted organic revenue growth for Q3 2021 was 8.2%. SS&C reported record adjusted consolidated EBITDA attributable to SS&C of $538.9 million for the quarter, $1,541.9 million for the first nine months 2021. Adjusted consolidated EBITDA margin increased to 42.6%, up 230 basis points from Q3 2020. Repurchased 2.1 million shares of common stock in Q3 2021 at an average price of $75.97 per share for $162.9 million. Paid down $317.8 million in debt for the first nine months in 2021, bringing consolidated net leverage ratio to 2.96x and our secured net leverage ratio to 1.97x consolidated EBITDA attributable to SS&C. In September, the vast majority of global offices re-opened and employees are attending in increasing numbers on a voluntary basis. SS&C will host a virtual analyst day on November 10th, 2021, featuring presentations from our C-suite executives, as well as several members of our senior management team. Q3 2021 Highlights

Q3 2021 financial highlights Metric Q3 2021 Q3 2020 $ +/- % +/- Adjusted Revenues ($M) $1,266.3 $1,156.2 $110.1 9.5% Adjusted Operating Income attributable to SS&C ($M) $524.1 $448.8 $75.3 16.8% Adjusted Consolidated EBITDA attributable to SS&C ($M) $538.9 $466.3 $72.6 15.6% Adjusted Net Income attributable to SS&C ($M) $352.9 $294.2 $58.7 20.0% Adjusted Diluted Earnings Per Share attributable to SS&C $1.32 $1.10 $0.22 20.0% Operating Cash Flow for nine months ended September 30 ($M) $944.9 $755.1 $189.8 25.1% Note: See appendix for reconciliation of non-GAAP financial measures

Operating cash flow was $944.9 M for the nine months ended September 30, 2021 Debt Paid down $317.8 M in debt for the first nine months in 2021 Net leverage ratio is 2.96x, secured net leverage ratio is 1.97x LTM consolidated EBITDA attributable to SS&C of $2,019.5 M Shareholder Returns Repurchased 2.1 million shares of common stock in Q3 2021 at an average price of $75.97 per share for $162.9 million. Quarterly dividend payout of $0.16 per share Debt review and capital allocation

Organic Growth Calculations 2021 1Adjustments include $3.8 M for out-of-pocket expense reimbursements, and $7.3 M for DST clients that terminated pre-acquisition. 2Adjustments include $5.6 M for DST clients that terminated pre-acquisition. 3Adjustments include $5.0 M for DST clients that terminated pre-acquisition. Q1 2021 Q2 2021 Q3 2021 Total Adjusted Revenues ($M) 1,235.4 1,261.0 1,266.3 Fx ($M) (16.1) (26.4) (10.4) Acquisitions ($M) (18.6) (17.8) (10.0) Organic Revenues ($M) 1,200.7 1,216.8 1,245.9 Adjustments ($M) 11.11 5.62 5.13 Adjusted Organic Revenues ($M) 1,211.8 1,222.4 1,251.0 Adjusted Organic Revenue Growth Rate (%) 2.9% 7.2% 8.2%

Adjusted revenue and margins Adjusted revenue ($M) Adjusted consolidated EBITDA margin (%) Note: See appendix for reconciliation of non-GAAP financial measures

Quarterly retention rate is based on a rolling prior twelve months. Yearly retention is the average of four quarters. Acquisitions are not included in retention rate calculation until one year post-acquisition. Revenue retention rates

Adjusted net income and adjusted diluted EPS attributable to SS&C Adjusted net income attributable to SS&C ($M) Adjusted diluted EPS attributable to SS&C Note: See appendix for reconciliation of non-GAAP financial measures

Alternative Assets under Administration ($B) Alternatives AuA has increased $480 billion since Q1 2020. $480 billion

Guidance SS&C does not provide reconciliations of guidance for Adjusted Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. SS&C is unable, without unreasonable efforts, to forecast certain items required to develop meaningful comparable GAAP financial measures. These items include acquisition transactions and integration, foreign exchange rate changes, as well as other non-cash and other adjustments as defined under the Company’s Credit agreement, that are difficult to predict in advance in order to include in a GAAP estimate. The unavailable information could have a significant impact on Q4 2021 and FY 2021 GAAP financial results. Q4 2021 FY 2021 Adjusted Revenues ($M) $1,225.0 – $1,275.0 $4,988.0 – $5,038.0 Adjusted Net Income attributable to SS&C ($M) $311.0 – $334.0 $1,312.0 – $1,335.0 Adjusted Diluted Earnings Per Share attributable to SS&C $1.17 – $1.25 $4.92 – $4.99 Cash from Operating Activities ($M) – $1,365.0 – $1,385.0 Capital Expenditures (% of revenue) – 2.6% – 3.0% Diluted Shares (M) 266.2 – 266.7 266.9 – 267.4 Effective Income Tax Rate (%) 26% 26%

AppendixDisclosures relating to non-GAAP financial measures

Reconciliation of revenues to adjusted revenues Adjusted revenues represents revenues adjusted to include a) amounts that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition and b) amounts that would have been recognized if not for adjustments to deferred revenue and retained earnings related to the adoption of ASC 606. Adjusted revenues is presented because we use this measure to evaluate performance of our business against prior periods and believe it is a useful indicator of the underlying performance of our business. Adjusted revenues is not a recognized term under generally accepted accounting principles (“GAAP”). Adjusted revenues does not represent revenues, as that term is defined under GAAP, and should not be considered as an alternative to revenues as an indicator of our operating performance. Adjusted revenues as presented herein is not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP measure we believe to be most directly comparable to adjusted revenues. The following is a breakdown of software-enabled services and license, maintenance and related revenues and adjusted software-enabled services and license, maintenance and related revenues.

Reconciliation of operating income to adjusted operating income Adjusted operating income represents operating income adjusted for amortization of intangible assets, stock-based compensation, purchase accounting adjustments for deferred revenue and related costs, ASC 606 adoption impact and other expenses. Adjusted operating income is presented because we use this measure to evaluate performance of our business and believe it is a useful indicator of our underlying performance. Adjusted operating income is not a recognized term under GAAP. Adjusted operating income does not represent operating income, as that term is defined under GAAP, and should not be considered as an alternative to operating income as an indicator of our operating performance. Adjusted operating income as presented herein is not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation between adjusted operating income and operating income, the GAAP measure we believe to be most directly comparable to adjusted operating income. Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition. Other includes expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance. These include expenses and income related to foreign currency transactions, facilities and workforce restructuring, legal settlements and business acquisitions. On July 15, 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted operating income attributable to noncontrolling interest represents adjusted operating income based on the ownership interest retained by the respective noncontrolling parties.

Reconciliation of net income to EBITDA, consolidated EBITDA and adjusted consolidated EBITDA EBITDA represents net income before interest expense, income taxes, depreciation and amortization. Consolidated EBITDA, defined under our Credit Agreement entered into in April 2018, as amended, is used in calculating covenant compliance, and is EBITDA adjusted for certain items. Consolidated EBITDA is calculated by subtracting from or adding to EBITDA items of income or expense described below. Adjusted Consolidated EBITDA is calculated by subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we use these measures to evaluate performance of our business and believe them to be useful indicators of an entity’s debt capacity and its ability to service debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not recognized terms under GAAP and should not be considered in isolation or as alternatives to operating income, net income or cash flows from operating activities as indicators of our operating performance. These measures are not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA to net income.

Reconciliation of net income to EBITDA, consolidated EBITDA and adjusted consolidated EBITDA Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the period as if the acquisition occurred at the beginning of the period, as well as cost savings enacted in connection with acquisitions. Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisitions (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to increase or decrease rent expense by the amount that would have been recognized if lease obligations were not adjusted to fair value at the date of acquisitions. Other includes expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance. These include expenses and income related to foreign currency transactions, investment gains and losses, facilities and workforce restructuring, legal settlements, business combinations and other items. On July 15, 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted Consolidated EBITDA attributable to noncontrolling interest represents adjusted Consolidated EBITDA based on the ownership interest retained by the respective noncontrolling parties.

Reconciliation of net income to adjusted net income attributable to SS&C and diluted earnings per share to adjusted diluted earnings per share attributable to SS&C Adjusted net income and adjusted diluted earnings per share attributable to SS&C represent net income and earnings per share attributable to SS&C before amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments and other items. We consider adjusted net income and adjusted diluted earnings per share attributable to SS&C to be important to management and investors because they represent our operational performance exclusive of the effects of amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments, loss on extinguishment of debt and other items, that are not operational in nature or comparable to those of our competitors. Adjusted net income and adjusted diluted earnings per share are not recognized terms under GAAP. Adjusted net income and adjusted diluted earnings per share do not represent net income or diluted earnings per share, as those terms are defined under GAAP, and should not be considered as alternatives to net income or diluted earnings per share as indicators of our operating performance. Adjusted net income and adjusted diluted earnings per share attributable to SS&C as presented herein are not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted net income and adjusted diluted earnings per share attributable to SS&C to net income and diluted earnings per share attributable to SS&C, the GAAP measures we believe to be most directly comparable to adjusted net income and adjusted diluted earnings per share.

Reconciliation of net income to adjusted net income and diluted earnings per share to adjusted diluted earnings per share Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition. Other includes expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance. These include expenses and income related to foreign currency transactions, investment gains and losses, facilities and workforce restructuring, legal settlements, business acquisitions and other items. An estimated normalized effective tax rate of approximately 26% for the three and nine months ended September 30, 2021 and 2020, respectively, has been used to adjust the provision for income taxes for the purpose of computing adjusted net income. On July 15, 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted net income attributable to noncontrolling interest represents adjusted net income based on the ownership interest retained by the respective noncontrolling parties.

XML

Document And Entity Information	Oct. 28, 2021
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Oct. 28, 2021
Entity Registrant Name	SS&C TECHNOLOGIES HOLDINGS, INC.
Entity Central Index Key	0001402436
Entity Emerging Growth Company	false
Entity File Number	001-34675
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	71-0987913
Entity Address, Address Line One	80 Lamberton Road
Entity Address, City or Town	Windsor
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06095
City Area Code	860
Local Phone Number	298-4500
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Security12b Title	Common stock, par value $0.01 per share
Trading Symbol	SSNC
Security Exchange Name	NASDAQ